This article reviews how connectivity can be used to enhance training to help address the challenges of accuracy and non-adherence when patients self-inject their medications.
Connected medical devices are poised to revolutionize health care and drug delivery.
They represent the future of health care for patients, pharmaceutical companies and HCPs, playing a vital role in the remote tracking and treatment of chronic illnesses, and delivering a range of benefits that include improved drug management, enriched patient experiences and enhanced patient outcomes. Connected devices also create market differentiation and enable value-based contracting.
For patients who self-inject their medications, adherence and satisfaction have long been common concerns due to the lack of adequate training. Nearly half of patients who self-inject receive no training on how to do so properly.
Training devices are critically important for the millions of patients across the globe who live with chronic illnesses. A standard of training must become part of the standard of care to create more confident, healthy – and ultimately, adherent – patients who self-administer their medications.
Connected drug delivery devices can support this standard of care and improve patient health outcomes by addressing the challenges of accuracy and non-adherence. This is a compelling value proposition for all stakeholders – patients, care providers, pharma companies and payers.
